Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

NMDA receptor regulation of rapid scaling and spinal excitability in fragile X syndrome.

Award Number: R21NS146918
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/11/2026
PERIOD OF PERFORMANCE END DATE: 04/30/2028

Group Awards By:

View Award Description

NMDA receptor regulation of rapid scaling and spinal excitability in fragile X syndrome. - NMDA receptor regulation of rapid scaling and spinal excitability in fragile X syndrome. Abstract Identifying the mechanisms that control the maturation of network excitability during development will be crucial to understanding how these networks are established with dysregulated activity in cases of neurodevelopmental disorders such as autism spectrum disorder (ASD). We are proposing to study a guiding principle for the maturation of network excitability during neonatal development. We have just recently published work in the chick embryo spinal cord showing that blockade of NMDA receptors triggers rapid compensatory changes in the strength of glutamatergic and GABAergic synapses, referred to as synaptic scaling. This rapid form of synaptic scaling was previously characterized in a very different model system - rodent hippocampal cultures and slices. The observation that rapid scaling has been identified in 2 very different systems illustrates the fundamental importance of this form of plasticity. In the current application we will study rapid scaling in the neonatal mouse spinal cord, as we have preliminary results suggesting this plasticity exists in mouse spinal neurons, and that some inputs are altered more than others (nonuniform). In Aim 1 we will identify which classes of neonatal mouse spinal neurons express AMPAergic (excitatory) and GABAergic (inhibitory) rapid scaling and assess the uniformity of this scaling. We hypothesize that the homeostatic scaling capacity will be correlated with NMDAR content and will impact the excitatory to inhibitory (E/I) balance within the network and therefore maturation of excitability. Interestingly several different autism spectrum disorder (ASD) models experience altered NMDAR function and altered E/I balance. It is therefore reasonable to suggest that NMDA-dependent rapid scaling may indeed be altered in these models of autism, thus changing their excitability. ASD models have significant delays in motor development, yet spinal cord studies in these model systems are surprisingly rare. In Aim 2 we will test the hypothesis that rapid scaling is dependent on NMDAR content and that this is altered in a mouse model of Fragile X Syndrome (FXS), the most common monogenetic cause of ASD. By understanding the mechanisms of homeostatic plasticity during circuit formation, we will better understand the maturation of network excitability in neurodevelopmental disorders like ASD.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $234,750 )
2026	2026	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	5/12/2026	NEW	$234,750
														Subtotal = $234,750

Grand Total All Awards = $234,750

Top

All Categories

About

Search

Reports

Data Submission

Award Information

NMDA receptor regulation of rapid scaling and spinal excitability in fragile X syndrome.

Award Number: R21NS146918

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/11/2026

PERIOD OF PERFORMANCE END DATE: 04/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer